Merck (MRK)’s stock surged by 41%, driven not significantly by revenue but rather by increased profits and heightened ...

Over the past two years, Merck ( MRK 0.19%) has faced several challenges, resulting in a decline in the company's share price ...

Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused ...

In the past week, Merck received a boost as Wells Fargo upgraded its rating, citing increased confidence in Merck’s drug pipeline and noting significant progress in regulatory approvals for new ...

Merck Animal Health plans a $985 million expansion of its manufacturing facility in De Soto. Merck Animal Health's expansion ...

A Manhattan federal jury found Merck & Co. discriminated against a director of compliance and risk management by terminating ...

The partners said a TROP2-targeting antibody drug conjugate succeeded in a late-stage trial, paving the way for potential ...

De Soto planners have delayed approval of Merck Animal Health's site plan to review fire lane and traffic flow details for the animal vaccine maker's expansion.

Merck MRK continues to face challenges with Gardasil, its second-largest product, which is a vaccine approved for the ...

On November 17, BofA analyst Tim Anderson raised the firm’s price target on Merck & Co., Inc. (NYSE:MRK) to $105 from $98 and ...

Merck Foundation underscores their long-term partnership with Angola First Lady to train healthcare providers and support ...

With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) ...